Methods and apparatus for endovascularly replacing a patient's heart valve
Methods for endovascularly replacing a patient's heart valve. In some embodiments, the method includes the steps of endovascularly delivering a replacement valve and an anchor to a vicinity of the heart valve, the anchor having a braid, and expanding the braid to a deployed configuration against the patient's tissue. The braid may be fabricated from a single strand of wire and/or may comprise at least one the feature.
Latest Sadra Medical, Inc. Patents:
This application is a continuation-in-part application of U.S. Ser. No. 10/746,280, filed Dec. 23, 2003.BACKGROUND OF THE INVENTION
Heart valve surgery is used to repair or replace diseased heart valves. Valve surgery is an open-heart procedure conducted under general anesthesia. An incision is made through the patient's sternum (sternotomy), and the patient's heart is stopped while blood flow is rerouted through a heart-lung bypass machine.
Valve replacement may be indicated when there is a narrowing of the native heart valve, commonly referred to as stenosis, or when the native valve leaks or regurgitates. When replacing the valve, the native valve is excised and replaced with either a biologic or a mechanical valve. Mechanical valves require lifelong anticoagulant medication to prevent blood clot formation, and clicking of the valve often may be heard through the chest. Biologic tissue valves typically do not require such medication. Tissue valves may be obtained from cadavers or may be porcine or bovine, and are commonly attached to synthetic rings that are secured to the patient's heart.
Valve replacement surgery is a highly invasive operation with significant concomitant risk. Risks include bleeding, infection, stroke, heart attack, arrhythmia, renal failure, adverse reactions to the anesthesia medications, as well as sudden death. Two to five percent of patients die during surgery.
Post-surgery, patients temporarily may be confused due to emboli and other factors associated with the heart-lung machine. The first 2-3 days following surgery are spent in an intensive care unit where heart functions can be closely monitored. The average hospital stay is between 1 to 2 weeks, with several more weeks to months required for complete recovery.
In recent years, advancements in minimally invasive surgery and interventional cardiology have encouraged some investigators to pursue percutaneous replacement of the aortic heart valve. See, e.g., U.S. Pat. No. 6,168,614. In many of these procedures, the replacement valve is deployed across the native diseased valve to permanently hold the valve open, thereby alleviating a need to excise the native valve and to position the replacement valve in place of the native valve.
In the endovascular aortic valve replacement procedure, accurate placement of aortic valves relative to coronary ostia and the mitral valve is critical. Some self-expanding valve anchors have had very poor accuracy in deployment, however. In a typical deployment procedure, the proximal end of the stent is not released from the delivery system until accurate placement is verified by fluoroscopy. The stent often jumps to another position once released, making it impossible to know where the ends of the stent will be after release with respect to the native valve, the coronary ostia and the mitral valve.
Also, visualization of the way the new valve is functioning prior to final deployment is very desirable. Due to the jumping action of some self-expanding anchors, and because the replacement valve is often not fully functional before final deployment, visualization of valve function and position prior to final and irreversible deployment is often impossible with these systems.
Another drawback of prior art self-expanding replacement heart valve systems is their relative lack of radial strength. In order for self-expanding systems to be easily delivered through a delivery sheath, the metal needs to flex and bend inside the delivery catheter without being plastically deformed. Expandable stent designs suitable for endovascular delivery for other purposes may not have sufficient radial strength to serve as replacement heart valve anchors. For example, there are many commercial arterial stent systems that apply adequate radial force against the artery wall to treat atherosclerosis and that can collapse to a small enough of a diameter to fit inside a delivery catheter without plastically deforming. However when the stent has a valve fastened inside it, and that valve must reside within the heart, as is the case in aortic valve replacement, the anchoring of the stent to vessel walls takes significantly more radial force, especially during diastole. The force to hold back arterial pressure and prevent blood from going back inside the ventricle during diastole will be directly transferred to the stent/vessel wall interface. Therefore, the amount of radial force required to keep the self-expanding stent/valve in contact with the vessel wall and not sliding is much higher than in stents that do not have valves inside of them. Moreover, a self-expanding stent without sufficient radial force will end up dilating and contracting with each heartbeat, thereby distorting the valve, affecting its function and possibly causing it to migrate and dislodge completely. Simply increasing strut thickness of the self-expanding stent is not a good solution as it increases profile and/or a risk of plastic deformation of the self-expanding stent.
In view of drawbacks associated with previously known techniques for endovascularly replacing a heart valve, it would be desirable to provide methods and apparatus that overcome those drawbacks.SUMMARY OF THE INVENTION
One aspect of the present invention provides methods for replacing a native aortic valve. Such methods involve endovascularly delivering a replacement valve and an anchor having an expandable braid. Delivery is preferably made to a site within the native aortic valve. Delivery is preferably made by actively foreshortening the anchor to radially expand the anchor to an expanded shape to secure the anchor at the anchor site. In some embodiments, the methods further include the step of locking the anchor in an expanded shape. In some embodiments, the methods include expanding a first step region of the anchor to a first diameter and a second region of the anchor to a second diameter larger than the first diameter.
In some embodiments, the foreshortening step of the methods herein comprises actively foreshortening the anchor to radially expand the anchor to an expanded shape to secure the anchor at the anchor site while avoiding interference with a mitral valve. In some embodiments, the foreshortening step comprises actively foreshortening the anchor to radially expand the anchor to a radially symmetrical expanded shape, a bilaterally symmetrical expanded shape or an asymmetrical expanded shape.
In some embodiments, the anchor is allowed to self-expand prior to the foreshortening step. In some embodiments, the foreshortening step comprises applying a proximally directed force on a deployment system interface at a proximal end or a distal end of the anchor. In some embodiments, the foreshortening step comprises applying a distally directed force on a deployment system interface at a proximal end of the anchor.INCORPORATION BY REFERENCE
All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
The present invention relates to a delivery system, apparatus and methods for endovascularly delivering and deploying an aortic prosthesis within a patient's native heart valve, referred to here out as replacing a patients heart valve. The delivery system includes a sheath assembly and a guide wire for placing the apparatus endovascularly within a patient and a user control allowing manipulation of the aortic prosthesis. The apparatus includes an anchor and a replacement valve. The anchor includes an expandable braid. In preferred embodiments, the expandable braid includes closed edges. The replacement valve is adapted to be secured within the anchor, and as such, be delivered endovascularly to patient's heart to replace the patient's native heart valve. More preferably, the apparatus and methods of the present invention contemplate the replacement of a patient's aortic valve.
Control handle 120 is coupled to multi-lumen shaft 108. A knob 122 disposed in slot 123 is coupled to the distal region control wires for controlling movement of the distal region of apparatus 10. Likewise, a knob 124 disposed in slot 125 is coupled to proximal region control wires 112 for control of the proximal region of apparatus 10. Handle 120 may also have a knob 126 for, e.g., decoupling the proximal and/or distal region control wires from apparatus 10, or for performing other control functions.
Apparatus 10 has an anchor 30 and a replacement valve 20. Anchor 30 preferably comprises a braid. Such braid can have closed ends at either or both its ends. Replacement valve 20 is preferably coupled to the anchor along posts 32. Post 32 therefore, may function as valve support and may be adapted to support the replacement valve within the anchor. In the embodiment shown, there are three posts, corresponding to the valve's three commissure points. The posts can be attached to braid portion of anchor 30. The posts can be attached to the braid's distal end, as shown in
Anchor 30 has also a plurality of buckles 34 attached to its proximal region, one for each post 32. Posts 32 and buckles 34 form a two-part locking mechanism for maintaining anchor 30 in a deployed or expanded configuration (e.g., as illustrated in
In this embodiment, anchor 30 is formed from collapsible and expandable wire braid. Anchor braid 30 is preferably self-expanding and is preferably formed from a material such as Nitinol, cobalt-chromium steel or stainless steel wire using one or more strands of wire. While the illustrated embodiment is formed from a single strand of wire, in other embodiments may benefit from a wire braid formed of 2-20 wires, more preferably 3-15 wires, or more preferably 4-10 wires.
Delivery and deployment of braided anchor 30 is similar to the delivery and deployment of the anchors described in U.S. patent application Ser. No. 10/746,280 filed Dec. 23, 2003, the disclosure of which is incorporated herein by reference. Specifically, in one embodiment described below, during deployment braided anchor 30 is actively foreshortened by proximally retracting the distal region control wires relative to control tubes 106 to expand and lock the anchor in place. In some embodiments, foreshortening expands anchor 30 to a radially symmetrical, bilaterally symmetrical, or asymmetrical expanded shape (as further described below). The foreshortening step can include expanding a first region of the anchor to a first diameter and a second region of the anchor to a second diameter larger than the first diameter. A third region may also be expanded to a diameter larger than the first diameter. The expansion of various regions of the anchor (e.g., the distal region) can be especially useful in locating the aortic valve and centering the anchor within it. Preferably, the secured anchor does not interfere with the mitral valve or the ostias. In some embodiments, the anchor is allowed to self expand prior to the foreshortening step.
As seen in
In its collapsed configuration, anchor 30 preferably has a collapsed delivery diameter between about 3 to 30 Fr, or more preferably 6 to 28 Fr, or more preferably 12 to 24 Fr. In some embodiments, anchor 30 in its collapsed configuration will have a length ranging from about 5 to about 170, more preferably from about 10 to about 160, more preferably from about 15 to about 150, more preferably from about 20 to about 140 mm, or more preferably from about 25 mm to about 130.
Similarly, in its expanded configuration, anchor 30 preferable has a diameter ranging between about 10 to about 36 mm, or more preferably from about 24 to about 33 mm, or more preferably from about 24 to about 30 mm. In some embodiments, anchor 30 in its expanded configuration will have a length ranging from about 1 to about 50, more preferably from about 2 to about 40, more preferably from about 5 to about 30, or more preferably from about 7 to about 20 mm.
Overall, the ratio of deployed to collapsed/sheathed lengths is preferably between about 0.05 and 0.5, more preferably about 0.1 to 0.35, or more preferably about 0.15 to 0.25. In any of the embodiments herein, anchor 30 in its expanded configuration preferably has a radial crush strength that maintains the anchor substantially undeformed in response to a pressure of up to 0.5 atm directed substantially radially inward toward the central axis, or more preferably up to 2 atm directed substantially radially inward toward the central axis. In addition, in any of the embodiments herein, the anchor has an axial spring constant of between about 10 to 250 g/cm, more preferably between about 20 to 200 g/cm, or more preferably between about 40 to 160 g/cm. In addition, in any of the embodiments herein, the anchor is preferably adapted to support the replacement valve at the anchor site in response to a differential pressure of up to 120 mm Hg, more preferably up to 240 mm Hg, or more preferably up to 320 mm Hg.
These parameters are not intended to be limiting. Additional parameters within the scope of the present invention will be apparent to those of skill in the art.
As seen in
The distal deployment system interface may include control wires that are controlled, e.g., by control knob 122 of control handle 120. Similarly, the proximal regions of anchor 30 may be pushed distally via a proximal deployment system interface at the proximal end of the anchor. The proximal deployment system interface is adapted to permit deployment system to apply a distally directed force to the proximal end of anchor 30 through, e.g., fingers 106, which are controlled by, e.g., Control knob 124 of control handle 120. The proximal deployment system interface may be further adapted to expand radially during application of a d distally directed force on the proximal end of the anchor. Preferably, the proximal deployment system interface is adapted to permit deployment system to apply a distally directed force on the proximal end of the anchor system through a plurality of deployment system fingers or tubes 106. Such expansion optionally may be assisted via inflation of a balloon catheter (not shown) reversibly disposed within apparatus 10, as described in U.S. patent application Ser. No. 10/746,280.
Once anchor 30 is fully deployed, posts 32 and buckles 34 of anchor 30 may be used to lock and maintain the anchor in the deployed configuration. In one embodiment, the control wires attached to posts 32 are threaded through buckles 34 so that the proximally directed force exerted on posts 32 by the control wires during deployment pulls the proximal locking end of posts 32 toward and through buckles 34. Such lock optionally may be selectively reversible to allow for repositioning and/or retrieval of apparatus 10 during or post-deployment. Apparatus 10 may be repositioned or retrieved from the patient until the two-part locking mechanism of posts 32 and buckles 34 of anchor 30 have been actuated. When the lock is selectively reversible, the apparatus may be repositioned and/or retrieved as desired, e.g., even after actuation of the two-part locking mechanism. Once again, further details of this and other anchor locking structures may be found in U.S. patent application Ser. No. 10/746,280. Locking mechanisms used herein may also include a plurality of levels of locking wherein each level of locking results in a different amount of expansion. For example, the proximal end of the post can have multiple configurations for locking within the buckle wherein each configuration results in a different amount of anchor expansion.
When apparatus 10 is placed across a patient's diseased heart valve, anchor 30 may be used to displace the patient's native valve leaflets, and replacement valve 20 will thereafter serve in place of the native valve. After final positioning and expansion, apparatus 10 may be decoupled from delivery system 100 by decoupling the proximal and distal region control wires from anchor 30. Decoupling may be actuated using knob 126 of handle 120. After decoupling, delivery system 100 then may be removed from the patient, thereby completing endovascular replacement of a patient's heart valve.
Prior to implantation of replacement valve apparatus described herein, it may be desirable to perform a valvuloplasty on the patient's diseased valve by inserting a balloon into the valve and expanding it using, e.g., saline mixed with a contrast agent. In addition to preparing the valve site for implant, fluoroscopic viewing of the valvuloplasty will help determine the appropriate size of replacement valve implant to use.
As shown in
Posts 32 may be coupled to anchor braid 30 via one or more distal holes 36b. For example, anchor braid 30 may be woven through holes 36b, or a suture may be routed through holes 36b and tied to the braid. Buckles 34 may likewise be attached to anchor braid 30 via weaving or suturing.
Alternative locks may be used to lock the anchor of the present invention in the foreshortened configuration. Preferably, a locking mechanism of the present invention can have multiple locking options such that locking can confer a plurality of amounts of expansion. Furthermore, the locking option can be employed asymmetrically to confer non-cylindrical shapes to the anchor. In
Advantageously, providing multiple arrowheads 46 along posts 32 yields a ratchet that facilitates in-vivo determination of a degree of foreshortening imposed upon apparatus of the present invention. Furthermore, optionally constraining appendages 48 of arrowheads 46 via eyelets 49 prevents actuation of lock 40″ (and thus deployment of apparatus of the present invention) even after male element 44′ has been advanced through female element 42. Only after a medical practitioner has removed the wire constraining appendages 48 is lock 40″ fully engaged and deployment no longer reversible.
Lock 40′″ of
In some embodiments, fixture 200 comprises approximately 6-20 posts, more preferably 8-18 posts, or more preferably 10-16 posts around its circumference, though any alternative number of posts may be provided. Likewise, fixture 200 preferably has a diameter of about 2-40 mm, more preferably 4-30 mm, or more preferably 6-20 mm, though any alternative diameter may be provided. The diameter of fixture 200 preferably is the diameter of the braid in its “at rest” configuration.
Fixture 200 can optionally further comprise circumferential grooves 206 to facilitate interweaving of a first section of wire underneath an adjacent section of wire. The fixture optionally also may comprise localized depressions or holes 208 in addition, or as an alternative, to grooves 206. Depressions 208 may be provided at locations where wire segments cross to act as a visual guide for formation of anchor braid 30, as well as to facilitate the interweaving of a first section of wire beneath an adjacent section of wire.
Referring now to
As seen in
After passing inner proximal posts 202a, wire W encircles fixture 200 in a helical spiral while extending towards the distal posts, as seen in
At distal inner posts 202b, wire W forms turn Tu and is rerouted back towards proximal inner posts 202a. It should be noted that wire W can form turn Tu in either inner posts 202 or outer posts 204. Turn Tu forms a closed end of the braid. Additional sets of inner and outer posts are also contemplated. The wire once again encircles fixture 200 in a full 360° helical revolution plus one additional post before reaching the proximal inner posts and being rerouted back towards the distal inner posts. This process is repeated with the wire repetitively interwoven at crossing locations between the proximal and distal posts, e.g., via grooves 206 and/or depressions 208, to define the cells of the braid that will provide anchor 30 with desired characteristics. As seen in
When anchor braid 30 is formed from a shape-memory material, the braid may be heat set such that it maintains a desired degree of expansion in an at-rest configuration. The heat set at-rest configuration may comprise, for example, the delivery configuration (e.g., collapsed configuration) of
Referring now to
Stress concentration may increase the rigidity of an anchor braid and/or may impede delivery and deployment, as well as sheathing, of the braid. Thus, in preferred embodiments, a group of cells can be configured to reduce the sheathing force as described herein. Furthermore, to enhance deliverability, stress concentration may require that anchor braid 30 be fabricated from a relatively thin wire W. However, thin wire may not provide anchor braid 30 with adequate radial strength to displace a patient's diseased native heart valve leaflets and/or to anchor apparatus 10 against a patient's anatomy. Conversely, use of a relatively thick wire W may increase stiffness, thereby precluding retrograde delivery of apparatus 10, as well as a risk of kinking at turns in the braid. Thus, in some embodiments, wires varying in thickness may be used, or multiple wires having different thickness may be woven together. Also, wires made from different materials may be used to form an anchor braid.
It may be desirable to reduce stress concentration at the edges of anchor 30 where wire W changes direction and/or to reduce the circumferential stiffness of the anchor braid. The edge characteristics of the anchor may be altered by altering the shape of substantially all anchor braid cells at the anchor's edge (e.g., distal edge and/or proximal edge). Wire turns that control the shape of the edge cells may be formed within anchor braid 30 by routing wire W around optional outer posts 204 of fixture 200 during formation of the braid.
In preferred embodiments, the edge cells may be wrapped using wire, string, or sutures, at a location where the wire overlaps after an end turn as is illustrated in
The edge cell configuration of
Referring now to
Localized reduction may be achieved via a localized etching and/or electropolishing process. Alternatively or additionally, localized grinding of the turns may be utilized. Additional processing techniques will be apparent to those of skill in the art. As seen in
Referring now to
With reference now to
Referring now to
In preferred embodiments, the middle section of the anchor may be composed of thicker wire(s) than edge section(s)
The anchors described herein can be, for example, radially symmetrical, bilaterally symmetrical, or asymmetrical. A radially symmetrical anchor is one for which symmetry exists across any diameter. A bilaterally symmetrical anchor is one for which symmetry exists across a finite number if diameters). An asymmetrical anchor is one for which there exists no diameter across which a symmetry may be found.
While preferred embodiments of the present invention are shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
1. A method for replacing a native aortic valve comprising:
- endovascularly delivering completely out of a delivery catheter a replacement valve and an anchor comprising an expandable braid to an anchor site within the native aortic valve; and then
- actively foreshortening the anchor to radially expand the anchor to an expanded shape to secure the anchor at the anchor site, wherein the foreshortening step comprises applying a distally directed force on a deployment system interface at a proximal end of the anchor.
2. The method of claim 1 wherein the foreshortening step further comprises applying a distally directed force on the deployment system interface without diametrically constraining the proximal end of the anchor.
3. The method of claim 1 wherein delivering the replacement valve and the anchor completely out of the delivery catheter comprises delivering the anchor to a partially expanded configuration.
4. The method of claim 1 wherein delivering the replacement heart valve and the anchor completely out of the delivery catheter comprises allowing the anchor to self-expand.
5. A method for replacing a native aortic valve comprising: endovascularly delivering a replacement valve and an anchor comprising an expandable braid to an anchor site within the native aortic valve; to self expand to a partially expanded configuration and
- actively foreshortening the anchor to radially expand the anchor to an expanded shape to secure the anchor at the anchor site, wherein actively foreshortening comprises applying at least one of a distally directed force on a proximal end of the anchor or a proximally directed force on a distal end of the anchor with delivery system.
6. The method of claim 5 wherein actively foreshortening comprises applying a distally directed force on a proximal end of the anchor and a proximally directed force on a distal end of the anchor.
7. The method of claim 5 wherein endovascularly delivering the replacement valve and the anchor comprises endovascularly delivering the replacement valve and the anchor completely out of a delivery catheter, and wherein the active foreshortening step occurs after the anchor and valve are delivered completely out of the delivery catheter.
8. A method for replacing a native aortic valve comprising:
- endovascularly delivering completely out of a delivery catheter a replacement valve and an anchor comprising an expandable braid to an anchor site within the native aortic valve; and then
- actively foreshortening the anchor to radially expand the anchor to an expanded shape to secure the anchor at the anchor site, wherein the foreshortening step comprises applying a proximally directed force on a distal end of the anchor.
9. The method of claim 8 wherein applying a proximally directed force on the anchor comprises applying a proximally directed force on the distal end a deployment system interface at of the anchor.
10. The method of claim 9 wherein the proximally directed force on the distal end of the anchor is applied with a deployment system.
11. The method of claim 8 wherein actively foreshortening the anchor also comprises applying a distally directed force on the anchor.
12. The method of claim 11 wherein applying the distally directed force on the anchor comprises applying a distally directed force on the proximal end of the anchor.
13. The method of claim 12 wherein the distally directed force on the proximal end of the anchor is applied by a deployment system.
|3628535||December 1971||Ostrowsky et al.|
|3642004||February 1972||Osthagen et al.|
|3868956||March 1975||Alfidi et al.|
|3874388||April 1975||King et al.|
|4056854||November 8, 1977||Boretos et al.|
|4106129||August 15, 1978||Carpentier et al.|
|4233690||November 18, 1980||Akins|
|4291420||September 29, 1981||Reul|
|4425908||January 17, 1984||Simon|
|4501030||February 26, 1985||Lane|
|4580568||April 8, 1986||Gianturco|
|4610688||September 9, 1986||Silvestrini et al.|
|4647283||March 3, 1987||Carpentier et al.|
|4648881||March 10, 1987||Carpentier et al.|
|4655771||April 7, 1987||Wallsten|
|4662885||May 5, 1987||DiPisa, Jr.|
|4665906||May 19, 1987||Jervis|
|4710192||December 1, 1987||Liotta et al.|
|4733665||March 29, 1988||Palmaz|
|4796629||January 10, 1989||Grayzel|
|4819751||April 11, 1989||Shimada et al.|
|4834755||May 30, 1989||Silvestrini et al.|
|4856516||August 15, 1989||Hillstead|
|4872874||October 10, 1989||Taheri|
|4909252||March 20, 1990||Goldberger|
|4917102||April 17, 1990||Miller et al.|
|4954126||September 4, 1990||Wallsten|
|4986830||January 22, 1991||Owens et al.|
|4994077||February 19, 1991||Dobben|
|5002559||March 26, 1991||Tower|
|5064435||November 12, 1991||Porter|
|5161547||November 10, 1992||Tower|
|5163953||November 17, 1992||Vince|
|5209741||May 11, 1993||Spaeth|
|5217483||June 8, 1993||Tower|
|5258042||November 2, 1993||Mehta|
|5332402||July 26, 1994||Teitelbaum et al.|
|5350398||September 27, 1994||Pavcnik et al.|
|5370685||December 6, 1994||Stevens|
|5389106||February 14, 1995||Tower|
|5397351||March 14, 1995||Pavcnik et al.|
|5411552||May 2, 1995||Andersen et al.|
|5425762||June 20, 1995||Muller|
|5431676||July 11, 1995||Dubrul et al.|
|5443495||August 22, 1995||Buscemi et al.|
|5507767||April 16, 1996||Maeda et al.|
|5545133||August 13, 1996||Burns et al.|
|5545211||August 13, 1996||An et al.|
|5554185||September 10, 1996||Block et al.|
|5575818||November 19, 1996||Pinchuk|
|5645559||July 8, 1997||Hachtman et al.|
|5667523||September 16, 1997||Bynon et al.|
|5674277||October 7, 1997||Freitag|
|5695498||December 9, 1997||Tower|
|5713953||February 3, 1998||Vallana et al.|
|5800456||September 1, 1998||Maeda et al.|
|5817126||October 6, 1998||Imran|
|5824041||October 20, 1998||Lenker et al.|
|5824043||October 20, 1998||Cottone, Jr.|
|5824053||October 20, 1998||Khosravi et al.|
|5824056||October 20, 1998||Rosenberg|
|5824064||October 20, 1998||Taheri|
|5840081||November 24, 1998||Andersen et al.|
|5843158||December 1, 1998||Lenker et al.|
|5855597||January 5, 1999||Jayaraman|
|5855601||January 5, 1999||Bessler et al.|
|5860996||January 19, 1999||Tower|
|5861028||January 19, 1999||Angell|
|5868783||February 9, 1999||Tower|
|5876448||March 2, 1999||Thompson et al.|
|5888201||March 30, 1999||Stinson et al.|
|5891191||April 6, 1999||Stinson|
|5907893||June 1, 1999||Zadno-Azizi et al.|
|5910154||June 8, 1999||Tsugita et al.|
|5911734||June 15, 1999||Tsugita et al.|
|5925063||July 20, 1999||Khosravi|
|5944738||August 31, 1999||Amplatz et al.|
|5954766||September 21, 1999||Zadno-Azizi et al.|
|5957949||September 28, 1999||Leonhardt et al.|
|5968070||October 19, 1999||Bley et al.|
|5984957||November 16, 1999||Laptewicz, Jr. et al.|
|6022370||February 8, 2000||Tower|
|6027520||February 22, 2000||Tsugita et al.|
|6027525||February 22, 2000||Suh et al.|
|6042598||March 28, 2000||Tsugita et al.|
|6042607||March 28, 2000||Williamson, IV et al.|
|6051104||April 18, 2000||Jang|
|6123723||September 26, 2000||Konya et al.|
|6143987||November 7, 2000||Tsugita|
|6146366||November 14, 2000||Schachar|
|6162245||December 19, 2000||Jayaraman|
|6165200||December 26, 2000||Tsugita et al.|
|6168579||January 2, 2001||Tsugita|
|6168614||January 2, 2001||Andersen et al.|
|6171327||January 9, 2001||Daniel et al.|
|6179859||January 30, 2001||Bates|
|6200336||March 13, 2001||Pavcnik et al.|
|6221006||April 24, 2001||Dubrul et al.|
|6221091||April 24, 2001||Khosravi|
|6241757||June 5, 2001||An et al.|
|6245102||June 12, 2001||Jayaraman|
|6258114||July 10, 2001||Konya et al.|
|6258115||July 10, 2001||Dubrul|
|6258120||July 10, 2001||McKenzie et al.|
|6270513||August 7, 2001||Tsuigita et al.|
|6277555||August 21, 2001||Duran et al.|
|6309417||October 30, 2001||Spence et al.|
|6319281||November 20, 2001||Patel|
|6327772||December 11, 2001||Zadno-Azizi et al.|
|6336934||January 8, 2002||Gilson et al.|
|6338735||January 15, 2002||Stevens|
|6348063||February 19, 2002||Yassour et al.|
|6352708||March 5, 2002||Duran et al.|
|6361545||March 26, 2002||Macoviak et al.|
|6371970||April 16, 2002||Khosravi et al.|
|6371983||April 16, 2002||Lane|
|6379383||April 30, 2002||Palmaz et al.|
|6398807||June 4, 2002||Chouinard et al.|
|6409750||June 25, 2002||Hyodoh et al.|
|6425916||July 30, 2002||Garrison et al.|
|6440164||August 27, 2002||DiMatteo et al.|
|6458153||October 1, 2002||Bailey et al.|
|6468303||October 22, 2002||Amplatz et al.|
|6475239||November 5, 2002||Campbell et al.|
|6482228||November 19, 2002||Norred|
|6494909||December 17, 2002||Greenhalgh|
|6503272||January 7, 2003||Duerig et al.|
|6508833||January 21, 2003||Pavcnik et al.|
|6527800||March 4, 2003||McGuckin, Jr. et al.|
|6530949||March 11, 2003||Konya et al.|
|6537297||March 25, 2003||Tsugita et al.|
|6540768||April 1, 2003||Diaz et al.|
|6562058||May 13, 2003||Seguin et al.|
|6592546||July 15, 2003||Barbut et al.|
|6592614||July 15, 2003||Lenker et al.|
|6610077||August 26, 2003||Hancock et al.|
|6622604||September 23, 2003||Chouinard et al.|
|6632243||October 14, 2003||Zadno-Azizi et al.|
|6635068||October 21, 2003||Dubrul et al.|
|6652571||November 25, 2003||White et al.|
|6652578||November 25, 2003||Bailey et al.|
|6663663||December 16, 2003||Kim et al.|
|6669724||December 30, 2003||Park et al.|
|6673089||January 6, 2004||Yassour et al.|
|6673109||January 6, 2004||Cox|
|6676698||January 13, 2004||McGuckin, Jr. et al.|
|6682558||January 27, 2004||Tu et al.|
|6682559||January 27, 2004||Myers et al.|
|6685739||February 3, 2004||DiMatteo et al.|
|6689144||February 10, 2004||Gerberding|
|6689164||February 10, 2004||Seguin|
|6692512||February 17, 2004||Jang|
|6695864||February 24, 2004||Macoviak et al.|
|6695865||February 24, 2004||Boyle et al.|
|6702851||March 9, 2004||Chinn et al.|
|6712843||March 30, 2004||Elliott|
|6719789||April 13, 2004||Cox|
|6730118||May 4, 2004||Spenser et al.|
|6730377||May 4, 2004||Wang|
|6733525||May 11, 2004||Yang et al.|
|6736846||May 18, 2004||Cox|
|6752828||June 22, 2004||Thornton|
|6758855||July 6, 2004||Fulton, III et al.|
|6773454||August 10, 2004||Wholey et al.|
|6790229||September 14, 2004||Berreklouw|
|6863668||March 8, 2005||Gillespie et al.|
|6887266||May 3, 2005||Williams et al.|
|6890340||May 10, 2005||Duane|
|6905743||June 14, 2005||Chen et al.|
|6911036||June 28, 2005||Douk et al.|
|6936067||August 30, 2005||Buchanan|
|6953332||October 11, 2005||Kurk et al.|
|6964673||November 15, 2005||Tsugita et al.|
|6969395||November 29, 2005||Eskuri et al.|
|6974464||December 13, 2005||Quijano et al.|
|6974474||December 13, 2005||Pavcnik et al.|
|6974476||December 13, 2005||McGuckin, Jr. et al.|
|6979350||December 27, 2005||Moll et al.|
|6984242||January 10, 2006||Campbell et al.|
|20010025196||September 27, 2001||Chinn et al.|
|20010032013||October 18, 2001||Marton|
|20010039450||November 8, 2001||Pavonik et al.|
|20010041928||November 15, 2001||Pavcnik et al.|
|20010044634||November 22, 2001||Don Michael et al.|
|20020010489||January 24, 2002||Grayzel et al.|
|20020032480||March 14, 2002||Spence et al.|
|20020032481||March 14, 2002||Gabbay|
|20020052651||May 2, 2002||Myers et al.|
|20020058995||May 16, 2002||Stevens|
|20020077696||June 20, 2002||Zadno-Azizi et al.|
|20020095173||July 18, 2002||Mazzocchi et al.|
|20020095209||July 18, 2002||Zadno-Azizi et al.|
|20020111674||August 15, 2002||Chouinard et al.|
|20020151970||October 17, 2002||Garrison et al.|
|20020161392||October 31, 2002||Dubrul|
|20020161394||October 31, 2002||Macoviak et al.|
|20020193871||December 19, 2002||Beyersdorf et al.|
|20030014104||January 16, 2003||Cribier|
|20030023303||January 30, 2003||Palmaz et al.|
|20030028247||February 6, 2003||Cali|
|20030036791||February 20, 2003||Philipp et al.|
|20030040771||February 27, 2003||Hyodoh et al.|
|20030040772||February 27, 2003||Hyodoh et al.|
|20030055495||March 20, 2003||Pease et al.|
|20030060844||March 27, 2003||Borillo et al.|
|20030109924||June 12, 2003||Cribier|
|20030125795||July 3, 2003||Pavonik et al.|
|20030130729||July 10, 2003||Paniagua et al.|
|20030149475||August 7, 2003||Hyodoh et al.|
|20030149476||August 7, 2003||Damm et al.|
|20030149478||August 7, 2003||Figulla et al.|
|20030153974||August 14, 2003||Spenser et al.|
|20030176884||September 18, 2003||Berrada et al.|
|20030181850||September 25, 2003||Diamond et al.|
|20030187495||October 2, 2003||Cully et al.|
|20030199913||October 23, 2003||Dubrul et al.|
|20030199971||October 23, 2003||Tower et al.|
|20030199972||October 23, 2003||Zadno-Azizi et al.|
|20030208224||November 6, 2003||Broome|
|20030212452||November 13, 2003||Zadno-Azizi et al.|
|20030212454||November 13, 2003||Scott et al.|
|20030216774||November 20, 2003||Larson|
|20030233117||December 18, 2003||Adams et al.|
|20040034411||February 19, 2004||Quijano et al.|
|20040039436||February 26, 2004||Spenser et al.|
|20040049224||March 11, 2004||Buehlmann et al.|
|20040049262||March 11, 2004||Obermiller et al.|
|20040049266||March 11, 2004||Anduiza et al.|
|20040073198||April 15, 2004||Gilson et al.|
|20040082904||April 29, 2004||Houde et al.|
|20040082967||April 29, 2004||Broome et al.|
|20040088045||May 6, 2004||Cox|
|20040093016||May 13, 2004||Root et al.|
|20040098112||May 20, 2004||DiMatteo et al.|
|20040111096||June 10, 2004||Tu et al.|
|20040116951||June 17, 2004||Rosengart|
|20040117004||June 17, 2004||Osborne et al.|
|20040122468||June 24, 2004||Yodfat et al.|
|20040127979||July 1, 2004||Wilson et al.|
|20040138694||July 15, 2004||Tran et al.|
|20040138742||July 15, 2004||Myers et al.|
|20040138743||July 15, 2004||Myers et al.|
|20040153094||August 5, 2004||Dunfee et al.|
|20040158277||August 12, 2004||Lowe et al.|
|20040167565||August 26, 2004||Beulke et al.|
|20040186563||September 23, 2004||Lobbi|
|20040204755||October 14, 2004||Robin|
|20040215339||October 28, 2004||Drasler et al.|
|20040225321||November 11, 2004||Krolik et al.|
|20040254636||December 16, 2004||Flagle et al.|
|20050075662||April 7, 2005||Pedersen et al.|
|20050085841||April 21, 2005||Eversull et al.|
|20050085842||April 21, 2005||Eversull et al.|
|20050085843||April 21, 2005||Opolski et al.|
|20050085890||April 21, 2005||Rasmussen et al.|
|20050090846||April 28, 2005||Pederson et al.|
|20050096692||May 5, 2005||Linder et al.|
|20050096734||May 5, 2005||Majercak et al.|
|20050096735||May 5, 2005||Hojeibane et al.|
|20050096736||May 5, 2005||Osse et al.|
|20050096738||May 5, 2005||Cali et al.|
|20050100580||May 12, 2005||Osborne et al.|
|20050107822||May 19, 2005||WasDyke|
|20050113910||May 26, 2005||Paniagua et al.|
|20050137695||June 23, 2005||Salahieh et al.|
|20050165352||July 28, 2005||Henry et al.|
|20050165477||July 28, 2005||Anduiza et al.|
|20050197695||September 8, 2005||Stacchino et al.|
|20050203614||September 15, 2005||Forster|
|20050203615||September 15, 2005||Forster|
|20050203616||September 15, 2005||Cribier|
|20050203617||September 15, 2005||Forster et al.|
|20050209580||September 22, 2005||Freyman|
|20050228472||October 13, 2005||Case et al.|
|20050251250||November 10, 2005||Verhoeven et al.|
|20050251251||November 10, 2005||Cribier|
|20050261759||November 24, 2005||Lambrecht et al.|
|20050267560||December 1, 2005||Bates|
|20050283231||December 22, 2005||Haug et al.|
|20050283962||December 29, 2005||Boudjemline|
|20060004439||January 5, 2006||Spenser et al.|
|20060004442||January 5, 2006||Spenser et al.|
|20060015168||January 19, 2006||Gunderson|
|WO 93/15693||August 1993||WO|
|WO 95/04556||February 1995||WO|
|WO 95/29640||November 1995||WO|
|WO 96/14032||May 1996||WO|
|WO 96/24306||August 1996||WO|
|WO 98/36790||August 1998||WO|
|WO 98/50103||November 1998||WO|
|WO 98/57599||December 1998||WO|
|WO 99/44542||September 1999||WO|
|WO 00/09059||February 2000||WO|
|WO 00/44308||August 2000||WO|
|WO 00/44313||August 2000||WO|
|WO 00/49970||August 2000||WO|
|WO 00/67661||November 2000||WO|
|WO 01/05331||January 2001||WO|
|WO 01/08596||February 2001||WO|
|WO 01/10320||February 2001||WO|
|WO 01/10343||February 2001||WO|
|WO 01/35870||May 2001||WO|
|WO 01/64137||September 2001||WO|
|WO 02/36048||May 2002||WO|
|WO 02/100297||December 2002||WO|
|WO 03/003943||January 2003||WO|
|WO 03/003949||January 2003||WO|
|WO 03/011195||February 2003||WO|
|WO 03/015851||November 2003||WO|
|WO 2004/019811||March 2004||WO|
|WO 2004/023980||March 2004||WO|
|WO 2004/041126||May 2004||WO|
|WO 2004/047681||June 2004||WO|
|WO 2005/084595||September 2005||WO|
|WO 2005/087140||September 2005||WO|
- Andersen, H.R. et al., “Transluminal implementation of artificial heart valves. Description of a new expandable aortic valve and initial results in implantation by catheter techniqe in closed chest pigs”. Euro Heart J. (1992) 13:704-708.
- Atwood, A. et al., “Insertion of Heart Valves by Catheterization”. Project Supervised by Prof. Y. Muftu of Northeaster University (2001-2002) 36-40.
- Bodnar, E. et al., Replacement Cardiac Valves, Pergamon Publishing Corporation, New York, (1991), 307-322.
- Boudjemline, Y. et al., “Percutaneous implantation of a valve in the descending aorta in lambs”. Euro. Heart J. (2002) 23:13, 1045-1049.
- Boudjemline, Y. et al., “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract”. J. of Am. College of Cardio. (2004) 43:6, 1082-1087.
- Boudjemline, Y. et al., “Percutaneous valve insertion: A new approach?” J. of Thoracic and Cardio. Surg. (2003) 125:3, 741-743.
- Boudjemline, Y. et al., “Steps Toward Percutaneous Aortic Valve Replacement.” Circulation (2002) 775-778.
- Cribier, A. et al., “Early Experience with Percutaneous Transcatheter Implantation of Heart Valve Prosthesis for the Treatment of End-Stage Inoperable Patients with Calcific Aortic Stenois”. J. or Am. Coll. of Cardio. (2004) 43:4, 698-703.
- Cribier, A., et al., “Percutaneous Transcatherer Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description,” Circulation (2002) 3006-3008.
- Cribier, A., et al., “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case”. Percutaneous Valve Technologies, Inc. (2002).
- Ferrari, M. et al., “Percutaneous transvascular aortic valve replacement with self expanding stent-valve device”. Poster from the presentation given at SMIT 2000, 12th International Conference (Sep. 5, 2000).
- Hijazi, Z.M., “Transcatheter Valve Replacement: A New Era of Percutaneous Cardiac Intervention Begins”. J. of Am. College of Cardio. (2004) 43:6, 1088-1089.
- Huber, C.H. et al., “Do valved stents compromise coronary flow?” European Journal of Cardio-thoracic Surgery, (2004) 25:754-759.
- Knudsen, L. L. et al., “Catheter-implanted prosthetic heart valves”. Int'l J. of Art. Organs, (1993) 16:5, 253-263.
- Kort, S. et al., “Minimally invasive aortic valve replacement: Echocardiographic and clinical results”. Am. Heart J. (2001) 142:3, 476-481.
- Love, C. et al., The Autogenous Tissue Heart Valve: Current Status, Journal of Caridac Surgery, (1991) 6:4, 499-507.
- Lutter, G. et al., “Percutaneous aortic valve replacement: An experimental study. I. Studies on implantation,” J. of Thoracic and Cardio. Surg. (2002) 123:4, 768-776.
- Moulopoulos, S. D. et al., “Catheter-Mounted Aortic Valves,” Annals of Thoracic Surg. (1971) 11:5, 423-430.
- Paniagua, D. et al., “Percutaneous heart valve in the chronic in vitro testing model”. Circulation (2002), 106:e51-e52, American heart Association, Inc.
- Paniagua, D. et al., Heart Watch (2004), Spring, 2004 Edition, Texas Heart Institute.
- Pavcnik, D. et al., “Percutaneous bioprosthetic venous valve: A long-term study in sheep”. J. of Vascular Surg. (2002) 35:3, 598-603.
- Phillips, S. J. at al., “A Temporary Catheter-Tip Aortic Valve: Hemodynamic Effects on Experimental Acute Aortic Insufficiency”. Annals of Thoracic Surg. (1976) 21:2, 134-136.
- Phillips, S. J. at al., “A Temporary Catheter-Tip Aortic Valve: Hemodynamic Effects on Experimental Acute Aortic Insufficiency”. Annals of Thoracic Surg. (1976) 21:2, 134-136.
- Stuart, M., “In Heart Valves, A Brave, New Non-Surgical World”. Start-Up (2004) 9-17.
- Vahanian, A. et al., “Percutaneous Approaches to Valvular Disease”. Circulation (2004) 109, 1572-1579.
- Van Herwerden, L. A. et al., “Percutaneous valve implantation: back to the future?” Euro. Heart J. (2002) 23:18, 1415-1416.
- Zhou, J. Q. et al., “Self-expandable valved stent of large size: off-bypass implantation in pulmonary position”. Eur. J. Cardiothorac. (2003) 24, 212-216.
- Salahieh, A. et al. U.S. Appl. No. 10/746,280 entitled “Repositionable heart valve and method”, filed Dec. 23, 2003.
- Salahieh, A. et al. U.S. Appl. No. 10/893,131 entitled “Methods and apparatus for endovascularly replacing a patient's heart valve”, filed Jul. 15, 2004.
- Salahieh, A. et al. U.S. Appl. No. 10/893,151, entitled “Methods and apparatus for endovascularly replacing a patient's heart valve”, filed Jul. 15, 2004.
- Salahieh, A. et al. U.S. Appl. No. 10/893,142, entitled “Methods and apparatus for endovascularly replacing a patient's heart valve”, filed Jul. 15, 2004.
- Salahieh, A. et al. U.S. Appl. No. 10/920,736, entitled “Apparatus and methods for protecting against embolization during endovascular heart replacement”, filed Aug. 17, 2004.
- Salahieh, A. et al., U.S. Appl. No. 10/746,240, entitled “Heart valve anchor and method”, filed Dec. 23, 2003.
- Salahieh, A. et al., U.S. Appl. No. 10/972,287, entitled “Leaflet engagement elements and methods for use thereof”, filed Oct. 21, 2004.
- Salahieh, A. et al., U.S. Appl. No. 10/971,535, entitled “Leaflet engagement elements and methods for use thereof”, filed Oct. 21, 2004.
- Salahieh, A. et al., U.S. Appl. No. 10/746,120, entitled “Externally expandable heart valve anchor and method”, filed Dec.23, 2003.
- Salahieh, A. et al., U.S. Appl. No. 10/982,388, entitled “Methods and apparatus for endovascularly replacing a heart valve”, filed Nov. 5, 2004.
- Salahieh, A. et al., U.S. Appl. No. 10/746,285, entitled “Retrievable heart valve anchor and method”, filed Dec. 23, 2003.
- Salahieh, A. et al., U.S. Appl. No. 10/982,692, entitled “Retrievable heart valve anchor and method”, filed Nov. 5, 2004.
- Salahieh, A. et al., U.S. Appl. No. 10/746,887, entitled “Low profile heart valve and delivery system”, filed Dec. 23, 2003.
- Salahieh, A. et al., U.S. Appl. No. 10/746,872, entitled “Locking heart valve anchor”, filed Dec. 23, 2003.
- Salahieh, A. et al., U.S. Appl. No. 10/911,059, entitled “Replacement valve and anchor”, filed Aug. 3, 2004.
- Salahieh, A. et al., U.S. Appl. No. 10/746,942, entitled “Two-piece heart valve and anchor”,filed Dec. 23, 2003.
- Salahieh, A. et al., U.S. Appl. No. 10/870,340, entitled “Everting heart valve”, filed Jun. 16, 2004.
- Boudjemline, Y. et al. Percutaneious implantation of a biological valve in the aorta to treat aortic valve insufficiency—a sheep study. Med Sci.Monit. (2002) vol. 8, No. 4, pp. BR113-116.
- Fawzi, et al., U.S. Appl. No. 11/155,309, entitled “Apparatus and methods for intravascular embolic protection,” filed Jun. 16, 2005.
- Salahieh, et al., U.S. Appl. No. 11/232,441, entitled “Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements,” filed Sep. 20, 2005.
- Salahieh, et al., U.S. Appl. No. 11/232,444, entitled “Methods and apparatus for ednovascular heart valve replacement comprising tissue grasping elements,” filed Sep. 20, 2005.
- Salahieh, et al., U.S. Appl. No. 11/274,889, entitled “Medical implant deployment tool,” filed Nov. 14, 2005.
- Salahieh, et al., U.S. Appl. No. 11/314,183, entitled “Medical Device Delivery,” filed Dec. 20, 2005.
- Salahieh, et al., U.S. Appl. No. 11/314,969, entitled “Methods And Apparatus For Performing Valvuloplasty,” filed Dec. 20, 2005.
- Salahieh, et al., U.S. Appl. No. 11/275,912, entitled “Medical Implant Delivery and Deployment Tool,” filed Feb. 2, 2006.
- Salahieh, et al., U.S. Appl. No. 11/275,913, entitled “Two-Part Package for Medical Implant,” filed Feb. 2, 2006.
- Salahieh, et al., U.S. Appl. No. 11/531,980, entitled “Externally expandable heart valve anchor and method,” filed Sep. 14, 2006.
- Salahieh, et al., U.S. Appl. No. 11/532,019, entitled “Methods and apparatus for endovascularly replacing heart valve,” filed Sep. 14, 2006.
- Haug, et al; U.S. Appl. No. 11/716,123, entitled “Methods and apparatus for endovascularly replacing a heart valve,” filed Mar. 9, 2007.
- Salahieh, et al; U.S. Appl. No. 11/706,549, entitled “Systems and Methods for Delivering a Medcial Implant,” filed Feb. 14, 2007.
- Salahieh, et al; U.S. Appl. No. 11/732,906 entitled “Assessing the location and performance of replacement heart valves,” filed Apr. 4, 2007.
Filed: Jul 15, 2004
Date of Patent: Feb 12, 2008
Patent Publication Number: 20050137693
Assignee: Sadra Medical, Inc. (Campbell, CA)
Inventors: Ulrich R. Haug (Campbell, CA), Hans F. Valencia (Berkeley, CA), Robert A. Geshlider (San Francisco, CA), Tom Saul (El Granada, CA), Amr Salahieh (Saratoga, CA), Dwight P. Morejohn (Davis, CA)
Primary Examiner: William H. Matthews
Attorney: Shay Glenn LLP
Application Number: 10/893,143
International Classification: A61F 2/24 (20060101);